Craft

Advanced
Taro

Taro

Stock Price

$43

2024-07-24

Market Capitalization

$1.6 B

2024-07-24

Revenue

$573 M

FY, 2023

Taro Summary

Company Summary

Overview
Taro is a research-based pharmaceutical company. It produces a wide range of prescription and over-the-counter products including tablets, capsules, suspensions, solutions, creams, and ointments. The company products are used in cardiology and neurology.
Type
Public
Status
Active
Founded
1950
HQ
Hawthorne, NY, US | view all locations
Website
https://www.taro.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

LocationsView all

3 locations detected

  • Hawthorne, NY HQ

    United States

    3 Skyline Dr

  • Brampton, ON

    Canada

    130 East Dr

  • Haifa, Haifa District

    Israel

    HaKitor St 14

Taro Financials

Summary Financials

Revenue (FY, 2023)
$573.0M
Gross profit (FY, 2023)
$268.3M
Net income (FY, 2023)
$25.4M
Cash (FY, 2023)
$154.5M
EBIT (FY, 2023)
$17.7M
Enterprise value
$1.5B

Competitors and Similar Companies

Compare competitors

Footer menu

Product

Solutions

Resources

Company

© Craft.co 2026
Share price data provided by IEX